SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-036570
Filing Date
2017-05-31
Accepted
2017-05-31 16:13:18
Documents
3
Period of Report
2017-05-24
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-14242_18k.htm 8-K 27655
2 EX-16.1 a17-14242_1ex16d1.htm EX-16.1 7320
3 GRAPHIC g142421kmi001.gif GRAPHIC 4516
  Complete submission text file 0001104659-17-036570.txt   42422
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37558 | Film No.: 17881169
SIC: 2834 Pharmaceutical Preparations